The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Create account Sign in

Coronary interventions

A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study

EuroIntervention 2015;11:541-548 published online ahead of print August 2014. DOI: 10.4244/EIJY14M08_06

Emanuele Barbato
Emanuele Barbato1, MD; Sonja Salinger-Martinovic2, MD; Dragan Sagic3, MD; Branko Beleslin4, MD; Mathias Vrolix5, MD; Aleksandar N. Neskovic6, MD; Nikola Jagic7, MD; Stefan Verheye8, MD; Zlatko Mehmedbegovic4, MD; William Wijns1*, MD
1. Cardiovascular Center Aalst, Aalst, Belgium; 2. Clinical Centre Nis, Nis, Serbia; 3. Institute for Cardiovascular Disease Dedinje, Belgrade, Serbia; 4. Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; 5. AZ St J

Aims: To report the six-month angiographic and two-year clinical outcome data from the first-in-man study with the Ultimaster DES, a thin-strut cobalt-chromium sirolimus-eluting stent (SE

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

bioresorbable polymerclinical researchsirolimus
Share on Facebook Share on Twitter Share on Linkedin

Read next article

Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial

Latest news

New issue
EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more
(3D volume-rendered CCTA LAA example)
January 17, 2020
Editorial
From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”
Robert Byrne
January 17, 2020
JAA
New this week: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more
January 21, 2020
TRIALS BOOK
Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...
(The Trials book is supported by Biotronik)
January 15, 2020
Guidance Papers
Guidelines, consensus & position papers
April 9, 2019
Editorial
The role of the Heart Team in the planning of aortic valve replacement
January 15, 2020
JAA
Last week's JAA's: Inferior caval valve implantation for severe tricuspid regurgitation
January 14, 2020